LABETOLOL Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

LABETOLOL Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses


IUPAC nomenclature




Labetolol is a mixed α/ß blocker.


Physiochemical Properties

1 Molecular weight 328.4 g/mol
2 Physical appearance Solid
3 Melting point 188°C
4 Solubility Water solubility is 3.56e-04 M
5 Octanol/water partition coefficient 2.7
6 Presence of ring Benzene
7 Number of chiral centers 2


Mechanism of Action

  • Labetolol selectively antagonizes α1– adrenergic receptors and it nonselectively antagonizes ß-adrenergic receptors.
  • It has having 3 times ß-blocking activity than α-blocking activity.
  • Antagonism of α-receptors leads to vasodilation and decreased vascular resistance, which further results in decreased blood pressure.
  • Antagonism of ß1-adrenergic receptors produces slight decrease in heart rate.
  • Antagonism of ß2-adrenergic receptors is responsible for the side effects of the drug like bronchospasms.
  • Labetolol produces a sustained vasodilation for a longer duration without the significant lowering in cardiac output or stroke volume, and a slight decrease in heart rate.


Structure Activity Relationship

  • The type of N-substitutions such as N-isopropyl and N-t-butyl eliminates α1-activity.
  • Arylalkyl groups with α-methyl substituent returns back the α­1-affinity but not the intrinsic activity.
  • The ß-blocking activity is almost 1.5 folds that of its α1-blocking activity.


Method of synthesis

i. N-alkylation of N-benzyl-N(4-phenyl-2-butyl)amine 5-bromoacetylsalicylamide forms aminoketone.

ii. Debenzylation of aminoketone by hydrogen using palladium-platinium on carbon catalyst yields labetolol.


Therapeutic Uses

Labetolol is used for treatment of:

  • Hypertension
  • Prevention of strokes
  • Prevention of heart attacks
  • Prevention of kidney problems

Side Effects

Side effects of Labetolol are:

  • Dizziness
  • Tiredness
  • Scalp tingling
  • Decreased libido
  • Lightheadedness



Q.1 Choose the correct option related to the correct physicochemical properties of drug labetolol.

I. Molecular weight is 266.34 gm/mol.

II. It is present in solid form.

III. Melting point is 188°C

a) I, II, III

b) II, III

c) I, III

d) I, II

Q.2 Match the following of the drugs with their correct IUPAC names.

i. Atenolol A. (±)-[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine
ii. Labetolol B. (RS)-2-Hydroxy-5-[1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl]benzamide
iii. Bisoprolol C. (RS)-1-{4-[(2-Isopropoxyethoxy)methyl]phenoxy}-


iv. Carvedilol D. (RS)-2-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide.

 a) i-B, ii-A, iii-C, iv-D

b) i-D, ii-A, iii-B, iv-C

c) i-A, ii-C, iii-D, iv-B

d) i-D, ii-A, iii-C, iv-B

Q.3 Pick the correct statement related with the mechanism of action of drug labetolol?

 a) It selectively antagonizes α1-adrenergic receptors and nonselectively antagonizes ß-adrenergic receptors .

b) It nonselectively antagonizes α-adrenergic receptors and nonselectively antagonizes ß-adrenergic receptors .

c) It selectively antagonizes α2-adrenergic receptors and selectively antagonizes ß2-adrenergic receptors .

d) It nonselectively antagonizes α-adrenergic receptors and nonselectively antagonizes ß-adrenergic receptors .

Q.4 Correct sequence for True/false for the classification of the drug can be?

  • Atenolol: selective ß1-adrenergic antagonist.
  • Labetolol: mixed α/ß blocker
  • Salmeterol: nonselective adrenergic agonist.
  • Methyldopa: nonselective α-adrenergic antagonist





Q.5 Complete the following sentence related with structure activity relationship of Labetolol-

‘The ß-blocking activity is almost ………. That of α-blocking activity.

a) Half

b) Quarter

c) Double

d) 1.5 folds

Q.6 The correct sequence for the steps for synthesis of drug Labetolol from N-benzyl-N(4-phenyl-2-butyl)amine 5-bromoacetylsalicylamide

I. N-alkylation

II. Debenzylation

III. Hydrolysis

 a) I – II

b) III – II

c) II – I

d) II – III

Q.7 Side effect of drug Labetolol?

a) Lightheadedness

b) scalp tingling

c) Decreased libido

d) All of the above


For More Standard and Quality Question Bank you can Join Our Test Series Programme for GPAT, NIPER JEE, Pharmacist Recruitment Exam, Drug Inspector Recruitment Exams, PhD Entrance Exam for Pharmacy

FREE GPAT online Test: Participate: Click Here












[1] Carey B, Whalley ET. β‐Adrenoceptor agonist activity of labetolol on the isolated uterus of the rat. British journal of pharmacology. 1979 Sep;67(1):13-5.

[2] Lemke TL, Williams DA, Foye WO. Principles of medicinal chemistry. Williams & Wilkins; 2017, 356.

[3] Vardanyan R, Hruby V. Synthesis of essential drugs. Elsevier; 2006 Mar 10.




Leave a Reply

Your email address will not be published. Required fields are marked *

20 + 6 =

Free Video Lectures of Pharmacy Exams
Apply now

Developed By Connect Globes